Page last updated: 2024-11-12
inotilone
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
inotilone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11644214 |
SCHEMBL ID | 12780446 |
MeSH ID | M0501391 |
Synonyms (10)
Synonym |
---|
inchi=1/c12h10o4/c1-7-4-11(15)12(16-7)6-8-2-3-9(13)10(14)5-8/h2-6,13-14h,1h3/b12-6- |
nlzqgbcuknuded-sdqbbnpisa- |
AKOS015896246 |
inotilone |
GE-0217 |
SCHEMBL12780446 |
(2z)-2-[(3,4-dihydroxyphenyl)methylidene]-5-methylfuran-3-one |
(2z)-2-((3,4-dihydroxyphenyl)methylene)-5-methyl-3(2h)-furanone |
cn7vxc9pks , |
3(2h)-furanone, 2-[(3,4-dihydroxyphenyl)methylene]-5-methyl-, (2z)- |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |